Non-small cell lung cancer
Conditions
Interventions
Experimental group:Segmentectomy with lymph node sampling
Control group:Lobectomy with lymph node sampling
Sponsors
Jiangsu Province Hospital, the First Affiliated Hospital of Nanjing Medical University
Eligibility
Sex/Gender
All
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: 1. Patient aged 18 to 75 years; 2. 6 mm = 1 L and >= 70%); 7. Both lung segmentectomy and lobectomy could achieve R0 resection; 8. No serious cardiopulmonary complications, and could withstand both lung segmentectomy and lobectomy; 9. No hilus pulmonis and mediastinal lymph node metastasis and no distant metastasis; 10. Written informed consent; 11. Single tumor nodule or the concomitant nodule < microinvasive tumor.
Exclusion criteria
Exclusion criteria: 1. The tumor is located in right middle lobe; 2. A history of other malignancies in the last 5 years (exclusion of early-staged thyroid cancer and cervical cancer in situ); 3. Have received preoperative anti-tumor therapy, including prior chemotherapy, radiation therapy, target therapy and so on; 4. Serious mental illness; 5. Pregnant and lactating women; 6. Congestive heart failure, myocardial infarction, severe stenosis of coronary artery within recent 6 months; 7. With the history of cerebral infarction or cerebral hemorrhage within 6 months; 8. With the history of sustained systemic corticosteroid therapy within 1 month; 9. Other unsuitable situations.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Disease-free survival; | — |
Countries
China
Contacts
Public ContactChen Liang
Jiangsu Province Hospital, the First Affiliated Hospital of Nanjing Medical University
Outcome results
None listed